Suppr超能文献

未经治疗的体质性生长和青春期发育延迟女孩的最终身高

Final height in girls with untreated constitutional delay in growth and puberty.

作者信息

Crowne E C, Shalet S M, Wallace W H, Eminson D M, Price D A

机构信息

Royal Manchester Childrens Hospital, Manchester, United Kingdom.

出版信息

Eur J Pediatr. 1991 Aug;150(10):708-12. doi: 10.1007/BF01958760.

Abstract

During a 10-year period, 23 girls compared to 118 boys presented with constitutional delay in growth and puberty. Of these girls, 15 were followed to final height to determine the outcome of the untreated condition in terms of both growth and psychological well-being. At presentation chronological age was 13.2 (1.7) years [mean (S.D.)], bone age delay 2.7 (0.9) years, standing height standard deviation score (SDS) -3.4 (0.9), and predicted adult height (PAH) SDS -1.3 (0.7) (Tanner-Whitehouse II method). Final height SDS was -1.5 (0.8) measured at 18.9 (2.6) years of age. Mean age at menarche was 15.6 (0.9) years. There was no significant difference between final adult height (FH) and PAH but there was a significant difference between FH and target height (P less than 0.001). Psychological questionnaires revealed no significant difference in self-esteem, marital or employment status between the patient and control groups. There was no significant correlation between self-esteem and FH but 80% felt their growth delay had affected success either at school, work or socially. Of the patients, 50% would have preferred treatment to advance their growth spurt. This study demonstrates that girls with constitutional delay in growth and puberty reached their PAH, although this was lower than the midparental heights. The girls also experienced significant distress due to delayed growth and puberty and treatment to advance growth should be considered more frequently.

摘要

在10年期间,有23名女孩与118名男孩出现生长和青春期体质性延迟。在这些女孩中,15名被追踪至最终身高,以从未经治疗的情况来确定生长和心理健康方面的结果。就诊时,实际年龄为13.2(1.7)岁[均值(标准差)],骨龄延迟2.7(0.9)岁,站立身高标准差评分(SDS)为-3.4(0.9),预测成年身高(PAH)SDS为-1.3(0.7)(坦纳-怀特豪斯II法)。在18.9(2.6)岁时测得的最终身高SDS为-1.5(0.8)。月经初潮的平均年龄为15.6(0.9)岁。最终成年身高(FH)与PAH之间无显著差异,但FH与靶身高之间存在显著差异(P<0.001)。心理问卷显示,患者组与对照组在自尊、婚姻或就业状况方面无显著差异。自尊与FH之间无显著相关性,但80%的人认为其生长延迟影响了学业、工作或社交方面的成功。在这些患者中,50%的人更希望接受治疗以促进生长突增。本研究表明,生长和青春期体质性延迟的女孩达到了她们的PAH,尽管这低于父母身高的中位数。这些女孩也因生长和青春期延迟而经历了显著的痛苦,应更频繁地考虑进行促进生长的治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验